Innovator Track - CVD

The Innovator Track’s Cardiovascular Disease (CVD) Cohort is a 12-month initiative designed for medical groups and health systems to explore how providers can better identify and manage CVD risk among their patients with Type 2 diabetes. Selected participants—in collaboration with clinical advisors and AMGA staff—are developing and implementing care processes that improve heart health for patients with diabetes.

  • Geisinger

  • Hattiesburg Clinic, P.A.

  • Kelsey-Seybold Clinic

  • Mercy Clinic-East Communities

  • Premier Medical Associates, P.C.

  • PriMed Physicians

  • Sharp Rees-Stealy Medical Group, Inc

  • Southwest Medical Associates, Inc.

  • Summit Medical Group, P.A.

  • SwedishAmerican Health System

  • Utica Park Clinic

  • Watson Clinic, LLP

These organizations submit Core Track data as well as additional measures related to CVD risk and prevention. Participating groups can view the CVD Cohort measurement specifications and additional resources by logging into the CVD Cohort Communities Page.

For questions, email Erica Taylor or call her at 703.838.0033, ext. 399.

Launched in spring 2018, the CVD Cohort is presented in collaboration with the Boehringer Ingelheim and Lilly Diabetes Alliance.